Clinical Trial Detail

NCT ID NCT03290937
Title Clinical Trial Evaluating the Safety and Response With PF-05082566, Cetuximab and Irinotecan in Patients With Advanced Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

colorectal cancer

Therapies

Cetuximab + Irinotecan + Utomilumab

Age Groups: senior child adult

No variant requirements are available.